XML 39 R26.htm IDEA: XBRL DOCUMENT
v3.25.1

INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of Financial Information of Investment | The summarized financial statements of Solasglas are presented below. Summarized Statements of Financial Condition of Solasglas Investments, LP
|  | March 31, 2025 |  | December 31, 2024
Assets |  |  |  |
Investments, at fair value |  | $ | 526,047 |  |  | $ | 504,828 |
Derivative contracts, at fair value |  | 35,843 |  |  | 8,925 |
Due from brokers |  | 264,229 |  |  | 188,296 |
Cash and cash equivalents |  | 27,375 |  |  | 40,354 |
Interest and dividends receivable |  | 294 |  |  | 1,536 |
Total assets |  | 853,788 |  |  | 743,939 |
Liabilities and partners’ capital |  |  |  |
Liabilities |  |  |  |
Investments sold short, at fair value |  | (287,314) |  |  | (234,977) |
Derivative contracts, at fair value |  | (3,498) |  |  | (4,452) |
Capital withdrawals payable |  | — |  |  | (4,000) |
Due to brokers |  | (1,429) |  |  | — |
Interest and dividends payable |  | (1,468) |  |  | (3,218) |
Accrued expenses and other liabilities |  | (404) |  |  | (180) |
Total liabilities |  | (294,113) |  |  | (246,827) |
Partners' capital |  | $ | 559,675 |  |  | $ | 497,112 |
GLRE’s share of Partners' capital |  | $ | 435,341 |  |  | $ | 387,144 |
Summarized Statements of Operations of Solasglas Investments, LP
|  | Three months ended March 31
|  | 2025 |  | 2024
Investment income |  |  |  |
Dividend income (net of withholding taxes) |  | $ | 1,490 |  |  | $ | 831 |
Interest income |  | 3,627 |  |  | 4,352 |
Total Investment income |  | 5,117 |  |  | 5,183 |
Expenses |  |  |  |
Management fee |  | (1,730) |  |  | (1,323) |
Interest |  | (1,701) |  |  | (1,334) |
Dividends |  | (761) |  |  | (704) |
Research and operating |  | (485) |  |  | (324) |
Total expenses |  | (4,677) |  |  | (3,685) |
Net investment income |  | 440 |  |  | 1,498 |
Realized and change in unrealized gains (losses) |  |  |  |
Net realized gain (loss) |  | 19,105 |  |  | 42,945 |
Net change in unrealized appreciation (depreciation) |  | 27,018 |  |  | (16,245) |
Net gain on investment transactions |  | 46,123 |  |  | 26,700 |
Net increase in Partners' capital (1) |  | $ | 46,563 |  |  | $ | 28,198 |
GLRE’s share of the increase in Partners' capital |  | $ | 32,197 |  |  | $ | 18,248 |
(1) The net increase in Partners’ capital is net of management fees and performance allocation presented below:
|  | Three months ended March 31
|  | 2025 |  | 2024
Management fees |  | $ | 1,730 |  |  | $ | 1,323 |
Performance allocation |  | 3,578 |  |  | 2,028 |
Total |  | $ | 5,308 |  |  | $ | 3,351 |

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration